Patrick E. Sigmon

Davis Polk advised the sales agent in connection with the SEC-registered at-the-market offering by CytomX Therapeutics, Inc. of its common stock for up to an aggregate amount of $75 million…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,300,000 shares of its common stock. The common stock is listed on the…

Davis Polk is advising an ad hoc group of lenders under VIP Cinema Holding, Inc.’s first-lien term loan facility and first-lien revolving credit facility in the chapter 11 restructuring of…

Davis Polk advised Comcast Corporation on its SEC-registered debt offering of €800 million aggregate principal amount of its 0.250% notes due 2027, €1.4 billion aggregate principal amount…

We are advising L Brands on the separation of Victoria’s Secret

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 6,500,000 shares of common stock of Applied Genetic Technologies…

Davis Polk advised Uniti Group Inc. in connection with a Rule 144A and Regulation S offering of $2.25 billion aggregate principal amount of 7.875% senior secured notes due 2025 issued by…

Davis Polk advised Reynolds Consumer Products Inc. on its $1.4 billion initial public offering of 54,245,500 shares of common stock, which includes the full exercise of the underwriters’…

Davis Polk advised Grupo Aval Acciones y Valores S.A. in connection with its global offering of $1 billion aggregate principal amount of 4.375% senior notes due 2030. The notes were issued…

Davis Polk advised Grayscale Investments, LLC, as sponsor, in connection with the registration of the common units of fractional undivided beneficial interest (“Shares”) of Grayscale…